Ethyl glucuronide (etg): Better than breathalyser or self-reports to detect covert short-term relapses into drinking

Alcohol and Alcoholism

Volumn 49, Issue 1, 2014, Pages 51-54

  Wetterling, T ^a,b   Dibbelt, L ^c   Wetterling, G ^a   Goder R ^d   Wurst, F ^e   Margraf, M ^f   Junghanns, K ^a,f  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Vivantes Klinikum Hellersdorf   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f AHG Klinik Holstein   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; BREATH TESTS; FEMALE; FOLLOW-UP STUDIES; GLUCURONATES; HUMANS; MALE; MIDDLE AGED; SELF REPORT; SUBSTANCE ABUSE TREATMENT CENTERS; TEMPERANCE; TIME FACTORS;

EID: 84894055192     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt155     Document Type: Article

References (28)

1. Albermann ME, MusshoffF, Doberentz E et al. (2012a) Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment. Int J Legal Med 126:757-64
2. Albermann ME, MusshoffF, Madea B. (2012b) A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethyl glucuronide and ethyl sulfate in urine validated according to forensic guidelines. J Chromatogr Sci 50:51-6
3. Anton RF, Youngblood M. (2006) Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol Clin Exp Res 30:1878-83
4. Anton RF, O'Malley SS, Ciraulo DA et al. COMBINE Study Research Group (2006) Combined Pharmacotherapies and Behavioural Interventions for Alcohol Dependence. JAMA 295:2003-17
5. Dahl H, Voltaire Carlsson A, Hillgren K et al. (2011a) Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence Alcohol Alcohol 46:278-82
6. Dahl H, Voltaire Carlsson A, Hillgren K et al. (2011b) Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence Alcohol Alcohol 46:278-82
7. Feuerlein W, Küfner H. (1989) A prospective multicentre study of inpatient treatment for alcoholics: 18-and 48-month follow-up (Munich Evaluation for Alcoholism treatment, MEAT). Eur Arch Psychiatry Neurol Sci 239:144-57
8. Helander A, Böttcher M, Fehr C et al. (2009) Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol 44:55-61
9. Helander A, Péter O, Zheng Y. (2012) Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol 47:552-7
10. Høiseth G, Bernard JP, Stephanson N et al. (2008) Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment. Alcohol Alcohol 43:187-91
11. Høiseth G, Nordal K, Pettersen E et al. (2012) Prolonged urinary detection times of EtG and EtS in patients with decreased renal function Alcohol Clin Exp Res 36:1148-51
12. Junghanns K, Graf I, Pflüger J et al. (2009) Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups. Addiction 104:921-6
13. Lahmek P, Michel L, Diviné C et al. (2012) Ethyl glucuronide for detecting alcohol lapses in patients with an alcohol use disorder J Addict Med 6:35-8
14. Mann K, Lehert P, Morgan MY. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:51-63
15. Mann K, Lemenager T, Hoffmann S et al. The PREDICT Study Team. (2012) Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol doi: 10.1111/adb.12012
16. Mutschler J, Grosshans M, Koopmann A et al. (2010) Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety. Clin Neuropharmacol 33:285-7
17. Project Match Research Group. (1997) Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 58:7-29
18. Stephanson N, Dahl H, Helander A et al. (2002) Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatographymass spectrometry. Ther Drug Monit 24:645-51
19. Stewart SH, Koch DG, Burgess DM et al. (2013) Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol Clin Exp Res 37:150-5
20. Thierauf A, Halter CC, Rana S et al. (2009) Urine tested positive for ethyl glucuronide after trace amounts of ethanol. Addiction 104:2007-12
21. WHO. (1992) ICD-10, Chapter F. Geneva
22. Wurst FM, Kempter C, Seidl S et al. (1999) Ethyl glucuronide-a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol 34:71-7
23. Wurst FM, Kempter C, Metzger J et al. (2000) Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 20:111-6
24. Wurst FM, Vogel R, Jachau K et al. (2003) Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res 27:471-6
25. Wurst FM, Wiesbeck GA, Metzger JW et al. (2004) On Behalf of the WHO/ISBRA study on biological state and trait markers of alcohol use and dependence. On sensitivity, specificity and the influence of various parameters on ethyl glucuronide levels in urine: results from theWHO/ISBRA Study. Alcohol Clin Exp Res 28:1220-8
26. Wurst FM, Müller-Spahn F, Wiesbeck GA et al. (2005) Direct ethanol metabolites such as ethyl glucuronide (EtG), ethyl sulfate (EtS), fatty acid ethyl esters (FAEEs), and phosphatidyl ethanol (Peth): a new line of sensitive and specific biomarkers. Alcohol Clin Exp Res 29:1268-75
27. Wurst FM, Dürsteler-MacFarland KM, Auwaerter V et al. (2008a) Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol Clin Exp Res 32:1552-7
28. Wurst FM, Haber PS, Wiesbeck G et al. (2008b) Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addict Biol 13:416-22